Opexa Therapeutics, Inc. 4
4 · Opexa Therapeutics, Inc. · Filed Apr 9, 2015
Insider Transaction Report
Form 4
Radhakrishnan Karthik
Chief Financial Officer
Transactions
- Exercise/Conversion
Subscription Rights (Right to Buy)
2015-04-08−50,000→ 0 totalExercise: $0.55From: 2015-03-13Exp: 2015-04-08→ See Footnote (50,000 underlying) - Exercise/Conversion
Warrants (Right to Buy)
2015-04-08+50,000→ 50,000 totalFrom: 2015-04-08Exp: 2018-04-08→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2015-04-08+50,000→ 124,659 total
Footnotes (2)
- [F1]The common stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Opexa Therapeutics, Inc. (the ?Company?) to all holders of the Company?s common stock and to holders of certain of the Company?s outstanding warrants. The subscription rights entitled each recipient thereof to purchase units (?Units?), each Unit consisting of one share of the Company?s common stock and one warrant representing the right to purchase one share of the Company?s common stock. The purchase price for each Unit was $0.55.
- [F2]Each warrant entitles the holder to purchase one share of the Company?s common stock at an exercise price of (i) $0.50 per share from the date of issuance through June 30, 2016 and (ii) $1.50 per share from July 1, 2016 through the expiration date of the warrants.